AU2001271744A1 - Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9 - Google Patents
Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9Info
- Publication number
- AU2001271744A1 AU2001271744A1 AU2001271744A AU7174401A AU2001271744A1 AU 2001271744 A1 AU2001271744 A1 AU 2001271744A1 AU 2001271744 A AU2001271744 A AU 2001271744A AU 7174401 A AU7174401 A AU 7174401A AU 2001271744 A1 AU2001271744 A1 AU 2001271744A1
- Authority
- AU
- Australia
- Prior art keywords
- zlrr9
- zlrr8
- zlrr7
- leucine
- rich repeat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21544600P | 2000-06-30 | 2000-06-30 | |
| US60/215,446 | 2000-06-30 | ||
| PCT/US2001/020999 WO2002002604A2 (en) | 2000-06-30 | 2001-07-02 | Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001271744A1 true AU2001271744A1 (en) | 2002-01-14 |
Family
ID=22803010
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001271589A Abandoned AU2001271589A1 (en) | 2000-06-30 | 2001-06-28 | Mammalian secreted proteins |
| AU2001271683A Abandoned AU2001271683A1 (en) | 2000-06-30 | 2001-06-29 | Novel secreted proteins |
| AU2001271744A Abandoned AU2001271744A1 (en) | 2000-06-30 | 2001-07-02 | Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9 |
| AU2001273164A Abandoned AU2001273164A1 (en) | 2000-06-30 | 2001-07-02 | Membrane associated protein zupari |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001271589A Abandoned AU2001271589A1 (en) | 2000-06-30 | 2001-06-28 | Mammalian secreted proteins |
| AU2001271683A Abandoned AU2001271683A1 (en) | 2000-06-30 | 2001-06-29 | Novel secreted proteins |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001273164A Abandoned AU2001273164A1 (en) | 2000-06-30 | 2001-07-02 | Membrane associated protein zupari |
Country Status (5)
| Country | Link |
|---|---|
| US (6) | US6822082B2 (en) |
| EP (1) | EP1294763A2 (en) |
| AU (4) | AU2001271589A1 (en) |
| CA (1) | CA2415075A1 (en) |
| WO (4) | WO2002002621A2 (en) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002018411A1 (en) * | 2000-08-28 | 2002-03-07 | Human Genome Sciences, Inc. | 7 human secreted proteins |
| US20030166107A1 (en) * | 1997-09-18 | 2003-09-04 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US7339033B2 (en) * | 1998-06-26 | 2008-03-04 | Genentech, Inc. | Pro1481 |
| WO2000036105A1 (en) * | 1998-12-18 | 2000-06-22 | Human Genome Sciences, Inc. | Prostacyclin-stimulating factor-2 |
| US7148330B2 (en) * | 1999-07-30 | 2006-12-12 | Schering Corporation | Binding compounds for IL-27 |
| EP1878796A3 (en) * | 1999-11-30 | 2008-01-23 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US7081517B2 (en) * | 2000-01-10 | 2006-07-25 | Chiron Corporation | Genes differentially expressed in breast cancer |
| US7164001B2 (en) | 2000-01-20 | 2007-01-16 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US20030096969A1 (en) * | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| WO2001094587A2 (en) * | 2000-06-06 | 2001-12-13 | Incyte Genomics, Inc. | Extracellular messengers |
| AU2001271589A1 (en) * | 2000-06-30 | 2002-01-14 | Zymogenetics Inc. | Mammalian secreted proteins |
| US20040044179A1 (en) * | 2000-07-25 | 2004-03-04 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PL373008A1 (en) * | 2001-05-10 | 2005-08-08 | Immunex Corporation | Cytokine polypeptides |
| GB0208925D0 (en) * | 2002-04-12 | 2002-05-29 | Univ Sheffield | Polypeptide |
| GB0214543D0 (en) * | 2002-06-24 | 2002-08-07 | Ares Trading Sa | Proteins |
| DE10254601A1 (en) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Gene products differentially expressed in tumors and their use |
| EP2251353B1 (en) * | 2003-08-07 | 2013-03-06 | ZymoGenetics, Inc. | Homogeneous preparations of IL-29 |
| ATE530560T1 (en) * | 2003-11-06 | 2011-11-15 | Danisco Us Inc | VEGF BINDING AND CARRIER PEPTIDES FOR THE TREATMENT OF SKIN DISEASES |
| DE102004024617A1 (en) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentially expressed in tumors gene products and their use |
| JP2008500064A (en) * | 2004-05-21 | 2008-01-10 | ザ ユーエービー リサーチ ファウンデーション | Variable lymphocyte receptor, related polypeptides and nucleic acids, and uses thereof |
| EP1628136A1 (en) * | 2004-08-19 | 2006-02-22 | B.R.A.H.M.S. Aktiengesellschaft | Method of diagnosis of disease using copeptin |
| US20060258586A1 (en) * | 2005-05-06 | 2006-11-16 | Sheppard Paul O | Compositions and uses of secreted polypeptide, Zsig98 |
| AU2006272937A1 (en) * | 2005-07-20 | 2007-02-01 | Bristol-Myers Squibb Company | Use of truncated cysteine IL28 and IL29 mutants to treat cancers and autoimmune disorders |
| EP1912668A2 (en) * | 2005-07-20 | 2008-04-23 | ZymoGenetics, Inc. | Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| CN101848932A (en) | 2007-06-28 | 2010-09-29 | 阿斯比奥制药株式会社 | Peptides with hypotensive activity |
| US9421239B2 (en) | 2008-10-22 | 2016-08-23 | Trustees Of Dartmouth College | Therapy and kit for the prevention and treatment of cystic fibrosis |
| US8999919B2 (en) * | 2008-10-22 | 2015-04-07 | Trustees Of Dartmouth College | Compositions and methods for inhibiting the interaction between CFTR and CAL |
| US9333235B2 (en) | 2008-10-22 | 2016-05-10 | Trustees Of Dartmouth College | Combination therapy and kit for the prevention and treatment of cystic fibrosis |
| WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
| KR20180029201A (en) | 2015-05-18 | 2018-03-20 | 티씨알2 테라퓨틱스 인크. | Compositions and methods for TCR reprogramming using fusion proteins |
| WO2016191263A1 (en) | 2015-05-22 | 2016-12-01 | Trustees Of Dartmouth College | Therapy and kit for the prevention and treatment of cystic fibrosis |
| WO2018026953A1 (en) | 2016-08-02 | 2018-02-08 | TCR2 Therapeutics Inc. | Compositions and methods for tcr reprogramming using fusion proteins |
| IL302917A (en) | 2016-10-07 | 2023-07-01 | Tcr2 Therapeutics Inc | Preparations and methods for reprogramming T-cell receptors using fusion proteins |
| JP7291396B2 (en) | 2016-11-22 | 2023-06-15 | ティーシーアール2 セラピューティクス インク. | Compositions and methods for TCR reprogramming using fusion proteins |
| CN113039197A (en) * | 2018-07-26 | 2021-06-25 | T细胞受体治疗公司 | Compositions and methods for TCR reprogramming using target-specific fusion proteins |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5412410A (en) * | 1993-01-04 | 1995-05-02 | Xerox Corporation | Ink jet printhead for continuous tone and text printing |
| WO1995023512A1 (en) * | 1994-03-03 | 1995-09-08 | Alexion Pharmaceuticals, Inc. | Terminal complement inhibitor fusion genes and proteins |
| CA2215387A1 (en) * | 1995-03-20 | 1996-09-26 | Michael R. Briggs | Modulators of ob gene and screening methods therefor |
| EP0937142A2 (en) * | 1996-07-09 | 1999-08-25 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| CA2268771C (en) * | 1996-10-01 | 2008-07-29 | Progenitor, Inc. | Polymorphisms and new genes in the region of the human hemochromatosis gene |
| WO2000055371A1 (en) * | 1999-03-18 | 2000-09-21 | Human Genome Sciences, Inc. | 27 human secreted proteins |
| US6046030A (en) * | 1997-09-22 | 2000-04-04 | Smithkline Beecham Corporation | Human LIG-1 homolog (HLIG-1) |
| WO1999025820A1 (en) * | 1997-11-17 | 1999-05-27 | Warner-Lambert Company | p53CP, A PROTEIN THAT SPECIFICALLY BINDS TO CONSENSUS p53 DNA BINDING SITES |
| US20020102604A1 (en) * | 1999-12-08 | 2002-08-01 | Milne Edwards Jean-Baptiste Dumas | Full-length human cDNAs encoding potentially secreted proteins |
| US6168920B1 (en) * | 1998-08-10 | 2001-01-02 | Incyte Genomics, Inc. | Extracellular adhesive proteins |
| WO2001057188A2 (en) * | 2000-02-03 | 2001-08-09 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| US6330562B1 (en) * | 1999-01-29 | 2001-12-11 | International Business Machines Corporation | System and method for managing security objects |
| US6842860B1 (en) * | 1999-07-23 | 2005-01-11 | Networks Associates Technology, Inc. | System and method for selectively authenticating data |
| AU781867B2 (en) * | 1999-09-29 | 2005-06-16 | Lexicon Genetics Incorporated | Human carboxypeptidases and polynucleotides encoding the same |
| GB2364477B (en) * | 2000-01-18 | 2003-11-05 | Ericsson Telefon Ab L M | Virtual private networks |
| JP2003520594A (en) * | 2000-01-19 | 2003-07-08 | ユニバーシティ オブ バージニア パテント ファウンデーション | Sperm-specific protein |
| WO2001055326A2 (en) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| WO2001055167A1 (en) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| AU2001271589A1 (en) * | 2000-06-30 | 2002-01-14 | Zymogenetics Inc. | Mammalian secreted proteins |
| US6938155B2 (en) * | 2001-05-24 | 2005-08-30 | International Business Machines Corporation | System and method for multiple virtual private network authentication schemes |
| US7003662B2 (en) * | 2001-05-24 | 2006-02-21 | International Business Machines Corporation | System and method for dynamically determining CRL locations and access methods |
| US7393081B2 (en) * | 2003-06-30 | 2008-07-01 | Semiconductor Energy Laboratory Co., Ltd. | Droplet jetting device and method of manufacturing pattern |
-
2001
- 2001-06-28 AU AU2001271589A patent/AU2001271589A1/en not_active Abandoned
- 2001-06-28 WO PCT/US2001/020638 patent/WO2002002621A2/en not_active Ceased
- 2001-06-28 US US09/893,737 patent/US6822082B2/en not_active Expired - Fee Related
- 2001-06-29 US US09/895,836 patent/US20020086367A1/en not_active Abandoned
- 2001-06-29 EP EP01950716A patent/EP1294763A2/en not_active Withdrawn
- 2001-06-29 AU AU2001271683A patent/AU2001271683A1/en not_active Abandoned
- 2001-06-29 CA CA002415075A patent/CA2415075A1/en not_active Abandoned
- 2001-06-29 WO PCT/US2001/020847 patent/WO2002002626A2/en not_active Ceased
- 2001-07-02 AU AU2001271744A patent/AU2001271744A1/en not_active Abandoned
- 2001-07-02 AU AU2001273164A patent/AU2001273164A1/en not_active Abandoned
- 2001-07-02 US US09/897,214 patent/US20020076779A1/en not_active Abandoned
- 2001-07-02 US US09/897,878 patent/US20020164688A1/en not_active Abandoned
- 2001-07-02 WO PCT/US2001/021167 patent/WO2002002636A2/en not_active Ceased
- 2001-07-02 WO PCT/US2001/020999 patent/WO2002002604A2/en not_active Ceased
-
2004
- 2004-02-12 US US10/777,578 patent/US20040147722A1/en not_active Abandoned
- 2004-10-20 US US10/970,713 patent/US20050214791A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002002626A2 (en) | 2002-01-10 |
| AU2001271683A1 (en) | 2002-01-14 |
| AU2001273164A1 (en) | 2002-01-14 |
| WO2002002621A3 (en) | 2002-08-15 |
| WO2002002604A2 (en) | 2002-01-10 |
| US20020076779A1 (en) | 2002-06-20 |
| US20020086367A1 (en) | 2002-07-04 |
| WO2002002636A3 (en) | 2002-05-02 |
| US20020164688A1 (en) | 2002-11-07 |
| WO2002002621A2 (en) | 2002-01-10 |
| WO2002002636A2 (en) | 2002-01-10 |
| US6822082B2 (en) | 2004-11-23 |
| US20020110855A1 (en) | 2002-08-15 |
| AU2001271589A1 (en) | 2002-01-14 |
| US20050214791A1 (en) | 2005-09-29 |
| WO2002002626A3 (en) | 2002-09-26 |
| CA2415075A1 (en) | 2002-01-10 |
| WO2002002604A3 (en) | 2003-01-16 |
| US20040147722A1 (en) | 2004-07-29 |
| EP1294763A2 (en) | 2003-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001271744A1 (en) | Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9 | |
| AU2001232799A1 (en) | Protein c derivatives | |
| GB0001704D0 (en) | Protein | |
| AU2002314181A1 (en) | Novel endothelially expressed dnas and proteins, and their use | |
| AU6594401A (en) | 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines | |
| AU2001264852A1 (en) | Lactobacillusbeta -glucuronidase and dna encoding the same | |
| AU2001240791A1 (en) | Sequence | |
| AU2001266689A1 (en) | 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof | |
| GB0124032D0 (en) | Protein | |
| AU2002216100A1 (en) | Dormancy - induced mycobacterium proteins | |
| AU2001252062A1 (en) | Steatosis-modulating factors and uses thereof | |
| AU2001244863A1 (en) | Apoptin-associating protein | |
| AU2002239747A1 (en) | Cystoskeleton-associated proteins | |
| AU8229901A (en) | Genes and proteins, and their uses | |
| GB0217548D0 (en) | Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12 | |
| AU2002252773A1 (en) | Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 | |
| GB0009181D0 (en) | Protein | |
| AU2001278777A1 (en) | Irap-binding protein | |
| AU2001241044A1 (en) | Mitf-associated proteins | |
| AU2001250047A1 (en) | Effector-specific protein assembly and uses thereof | |
| IL150774A0 (en) | Apoptin-associating protein | |
| AU2001294911A1 (en) | Carbohydrate-associated proteins | |
| AU2001239742A1 (en) | Nucleic acids, encoding human crsp1 and uses thereof | |
| AU2001260116A1 (en) | Human dcc-like proteins | |
| AU2001277614A1 (en) | Novel proteins |